
Vaccinations have been given to the first volunteers in a Phase 1 trial of Moderna’s experimental HIV vaccine, the company has announced. The vaccine uses mRNA technology — similar to that utilized in breakthrough COVID vaccines — to deliver HIV-specific antigens that could trigger an immune response against the virus that causes AIDS, the company… read on > read on >